DR.INFO is one of the more serious European medical AI entrants. It combines cited answers, medical-device positioning, drug and guideline search, visual abstracts, and published pilot data — a more mature public profile than many tools in the clinical AI search category. Here is what doctors should know.
What Is DR.INFO?
DR.INFO describes itself as an AI assistant and educational tool for clinicians and medical students, delivering cited, guideline-based answers in seconds. Its homepage positions the product around "redefining how physicians access medical knowledge," with features including evidence-based summaries, inline citations with direct links and page markers, guardrailing, visual abstracts, drug databases, and clinical guideline search.
It is operated by Synduct GmbH, based in Munich. DR.INFO's about page lists founders Valentine Emmanuel, Dr Miguel Romano, Dr Rogerio Corga da Silva, and Michiel van der Heijden. The company claims 95.4% USMLE accuracy and top ranking on HealthBench Hard — OpenAI's physician-designed benchmark for complex medical AI conversations.
What Features Does DR.INFO Offer?
Cited clinical answers. Each response includes inline citations with direct links and page markers — clinicians can verify the source immediately. Sources include PubMed, FDA, EMA, and international clinical guidelines.
Visual abstracts. DR.INFO generates visual summaries that turn complex studies into graphical teaching formats. The Pro tiers include unlimited visual abstracts — limited in the free tier.
Drug databases and guideline search. Drug information retrieval and clinical guideline search across international sources.
Follow-up questions and guardrailing. The system prompts follow-up questions for clinical context and includes guardrailing to flag when queries fall outside its intended scope.
API access. DR.INFO offers an "Evidence First Search" API for healthcare applications, retrieving answers from guidelines, medical journals, and drug databases.
Organisation tier. Hospital, clinic, and institutional deployment with EHR/EMR connection, speech-to-speech, SSO, and collaboration features.
What Does CE-Marked Medical AI Mean in This Context?
DR.INFO says it is CE-marked under EU MDR 2017/745, hosted in the EU, and GDPR-aligned. It also claims compliance with the EU AI Act and HIPAA. The company says it is used by physicians at NHS institutions, University Hospital Zürich, and McGill University.
Its product label provides a careful intended-purpose boundary: DR.INFO is described as an informational and educational software device for qualified healthcare professionals. The label explicitly states that it is not to be used to inform diagnosis, treatment, or medical decision-making, and that it is not intended for emergency or time-critical decisions. Outputs must be independently reviewed and verified by the responsible healthcare professional.
This distinction matters. The marketing positions DR.INFO as a clinical AI assistant. The product label positions it as an informational and educational tool with explicit boundaries on clinical decision-making. Doctors should understand both positions when evaluating the product.
What the Pilot Study Found
A 2026 prospective single-arm pilot study, published in Cureus, evaluated DR.INFO v1.0 across Portuguese healthcare institutions. Twenty-nine physicians and medical students used the tool over five working days within a two-week period.
Among the 16 participants who completed final evaluation, reported outcomes were positive: perceived time saving scored 4.27 out of 5, perceived decision support scored 4.16 out of 5, and Net Promoter Score was 81.2.
The study is promising but early. It was small (29 participants, 16 completers), single-arm (no comparator), short-duration (five days), and measured perceived outcomes rather than objective clinical metrics. The authors themselves conclude that larger controlled studies with objective outcome measures and independent accuracy verification are still needed. This is intellectually honest — and should inform how clinicians weigh the evidence.
How DR.INFO Compares with Other Clinical AI Search Tools
DR.INFO is best understood as a European clinical reference assistant — CE-marked, cited, with visual abstracts and drug/guideline search. It sits in the same broad category as OpenEvidence (US-focused, peer-reviewed literature), Praxis Medicine (emerging UK-focused clinical search), AMBOSS AI Mode (curated evidence with education heritage), and iatroX (UK-focused clinical search with calculators and exam preparation).
The tools differ by geography, workflow, source strategy, and intended use — not just by answer quality on a single prompt.
Where iatroX Fits for UK Clinicians
DR.INFO is best understood as a European clinical reference assistant. iatroX is best understood as a UK-focused clinical knowledge platform: cited clinical answers, calculators, exam preparation, and clinician learning workflows in one place. UKCA-marked, MHRA-registered. Free.
For UK clinicians, the relevant question is not only whether a tool is cited or CE-marked, but whether it fits UK clinical workflow, UK guideline reality, and the practical tasks doctors perform every day — from clinical queries to exam revision to clinical scoring.
Try Ask iatroX for UK-focused clinical questions, calculators, and exam preparation →